BMRN

BioMarin Pharmaceutical
D

BMRN

59.460
USD
-1.19
(-1.96%)
مغلق
حجم التداول
0
الربح لكل سهم
4
العائد الربحي
-
P/E
18
حجم السوق
11,417,188,175
أصول ذات صلة
ALNY
ALNY
7.04
(1.64%)
435.18 USD
EXEL
EXEL
-0.310
(-0.82%)
37.410 USD
GILD
GILD
0.050
(0.05%)
110.350 USD
INCY
INCY
0.575
(0.74%)
78.230 USD
I
IONS
0.365
(0.90%)
41.065 USD
NBIX
NBIX
-2.755
(-2.15%)
125.590 USD
REGN
REGN
5.11
(0.92%)
560.19 USD
R
RGEN
1.530
(1.37%)
113.560 USD
S
SRPT
1.740
(10.71%)
17.980 USD
المزيد
الأخبار المقالات

العنوان: BioMarin Pharmaceutical

القطاع: Healthcare
الصناعة: Biotechnology
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline oftreatments in development.